The second batch of centralized procurement of 32 varieties decreased by 53% on average
-
Last Update: 2020-01-17
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The second batch of drugs were purchased by the state, covering the treatment fields of diabetes, hypertension, anti-tumor and rare diseases 122 enterprises participated in the bidding, and 24 foreign-funded enterprises The average price of 32 varieties decreased by 53%, of which the average price of foreign original drugs decreased by 82%, and the average price of generic drugs decreased by 51% Acarbose, a diabetes drug, was purchased nearly 2 billion tablets this time, with the quotations of 13.96 yuan, 9.6 yuan and 5.42 yuan respectively from China, the United States, East China, LVYE pharmaceutical and Bayer Bayer's single conversion price is 0.1807 yuan, which is nearly 80% lower than the required maximum effective bidding price.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
